Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 745-754 of 2072


San Diego Woman Sues 23andMe Over DNA Testby Gary RobbinsUT San DiegoDecember 3rd, 2013A class-action lawsuit alleges that 23andMe knowingly misled consumers into thinking that its DNA test kits produce a reliable look at a person’s relative risk for hundreds of diseases and disorders.
Genetic Testing Should Adhere to Medical, Not Business, Ethics: FDA's Regulation of 23andMe Is a Welcome Move for Consumersby Karuna JaggarHuffington PostDecember 1st, 2013The truth is that we still understand very little about how our genes interact with our environment, and our individual choices, to impact our health.
Linking Genes to Diseases by Sifting Through Electronic Medical Recordsby Carl ZimmerThe New York TimesNovember 28th, 2013In a new approach called phenome-wide association studies, scientists start with a gene variant and search among thousands of electronic medical records for conditions that match.
Are Three Parents One Too Many?[Quotes CGS]by Stephen L. CarterBloombergNovember 27th, 2013The U.K. may soon approve a regulatory proposal that would allow scientists to create a human embryo using the DNA of three individuals. What’s striking is how the many opponents span the political spectrum.
23andMe Is Terrifying, But Not for the Reasons the FDA Thinksby Charles SeifeScientific AmericanNovember 27th, 2013As the FDA frets about the accuracy of 23andMe’s tests, it is missing their true function, and consequently the agency has no clue about the real dangers they pose.
Personalized Cancer Treatments Suffer Setbackby Erika Check HaydenNatureNovember 27th, 2013Much hope has been placed on therapies that play on the same mutations that make cells cancerous — but selecting the right drugs may be more complicated than expected.
FDA Bans 23andme Personal Genetic Tests[Quotes CGS's Marcy Darnovsky]BBC NewsNovember 26th, 2013The US Food and Drug Administration has imposed a ban on a company offering personal genetic screening to the general public.
FDA’s Warning to 23andMe is a Welcome Step toward Responsible Oversight, says Center for Genetics and Society [Press statement]November 26th, 2013The US Food and Drug Administration has ordered 23andMe to “immediately discontinue marketing” its direct-to-consumer genetic tests.
Cambridge Company Embarks on Genome Engineeringby Callum BorchersThe Boston GlobeNovember 25th, 2013A new life-science company aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue.
My Deadly Disease Was Just a Bugby Lukas Hartmannctrl+verlustNovember 25th, 2013An update to the author's 23andMe report informed him that he had the mutations to develop a life-threatening disease. Except that he didn't. This is his story.
Displaying 745-754 of 2072  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760